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According to the idea that the central serotonergic system has a modulatory function
on behavior and personality in general, we aimed to highlight its association to
habitual positive emotionality. In a placebo-controlled double-blind and randomized
cross-over neuroendocrine challenge design (n = 72 healthy males) we investigated the
association of the central serotonergic responsivity, 5-HTTLPR-genotype as well as their
combined effects on positive emotionality. Regression analyses revealed an involvement
of the serotonergic system in positive emotionality. There was, however, no direct
association between positive emotionality and cortisol responses to S-citalopram; rather
5-HTTLPR-genotype showed an association (p < 0.05). That is, positive emotionality
scores increased with the number of s-alleles carried by the individuals. Most notable
was the moderating role of 5-HTTLPR-genotype (p < 0.05) on the association between
acute serotonergic responsivity and positive emotionality. Indeed, this association was
only found in ss-homozygotes, in which the acute responsivity of the serotonergic
system additionally seems to contribute to the level of positive emotionality (r = 0.70,
p < 0.05). The findings correspond to previous research demonstrating that the 5-HTTLPR
is not only involved in the negative-emotional aspects of behavior and temperament,
but is associated, moreover, with positive affectivity—supporting the assumption of its
valence-neutrality. In addition, our data are in line with the idea of possible influences of
the 5-HTTLPR-genotype on early neuronal development. They also indicate the need for
further studies in order to clearly elucidate the role of the serotonergic system and its
subcomponents in the regulation of positive emotionality.
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INTRODUCTION
The central serotonergic system controls a wide range of pro-
cesses (e.g., Lucki, 1998), wherein it is thought to have general
non-specific inhibitory effects (Spoont, 1992). Most research has
focused on the involvement of serotonin in psychopathology
and negative affectivity, wherefore its potential contribution to
positive affectivity has mostly been disregarded.
In his neurobiological theory Depue explicitly links the sero-
tonergic system to these inhibitory processes on the neural
and behavioral level, presuming it to function as a threshold-
modulator facilitating the elicitation of avoidance- as well as
approach-behavior in case of reduced functionality (Depue and
Collins, 1999; Depue and Fu, 2011). It is, therefore, thought to be
“valence-neutral” and should modulate negative as well as posi-
tive emotionality. On this background, the present study aims to
further elucidate the role of interindividual variations in the func-
tionality of the serotonergic system regarding the trait of positive
emotionality—i.e., stable dispositions associated with frequent
experiencing of positive affect, approach motivation and behav-
ior, reflecting interindividual differences in underlying emotional
response systems (Depue et al., 1994; Tellegen andWaller, 2008).
Eligible methods to assess the general activity of the cen-
tral serotonergic system are neuroendocrine challenge paradigms,
whereby the hormonal response to a serotonergic agonist indexes
its net responsivity (Yatham and Steiner, 1993). Few serotonergic
challenge-studies have reported data regarding traits of posi-
tive emotionality (i.e., extraversion), most of which have not
shown a link between extraversion and serotonergic responsiv-
ity using different substances (e.g., Manuck et al., 1998; Flory
et al., 2004; Brummett et al., 2008; Kuepper et al., 2010). Indeed,
Reist et al. (1996) demonstrated a positive association of the
cortisol response to paroxetin (indicating a diminished sero-
tonergic responsivity) in healthy males. Further evidence stems
from challenge-studies assessing mood over several consecutive
days. While Zald and Depue (2001) showed a blunted prolactin
response to fenfluramine to be associated with enhanced aver-
aged negative as well as positive affect [i.e., the two independent
dimensions of mood, as postulated by Watson et al. (1988)]
in healthy males, Flory et al. (2004) only found an association
with positive affect, albeit in opposite direction, in a considerably
larger mixed-sex sample. Summarily, there are indications of an
association of the responsivity of the serotonergic system with at
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least some aspects of positive emotionality; particularly when the
affective-component is measured [i.e., indicated by moderately
stable indicators of mood, measured over several weeks (Zald and
Depue, 2001)].
Genetic variations could contribute to differences in sero-
tonergic responsivity. One of the most intensively investigated
serotonin-related polymorphisms is the 5-HTTLPR (serotonin
transporter-gene-linked polymorphic region) within the pro-
moter of the serotonin-transporter (5-HTT) gene (SCL6A4).
The deletion/insertion of a repeat-element results in a short
(s-allele) and a long allele (l-allele) (Lesch et al., 1996). Most
research regarding the 5-HTTLPR and personality in healthy vol-
unteers has stressed traits of negative emotionality (e.g., Munafo
et al., 2009). Concerning positive emotionality, a meta-analysis by
Munafo et al. (2003) concluded that there is no association with
approach traits, which has been confirmed subsequently (Sen
et al., 2004; Munafo et al., 2006; Kazantseva et al., 2008; Fox et al.,
2009; Terracciano et al., 2010).
As temperamental traits are defined as emerging from a gen-
eral sensitivity for trait-congruent emotional stimuli (e.g., Gray,
1982; Depue and Collins, 1999), studies assessing this responsive-
ness could additionally be consulted. Alongside an altered atten-
tion to unpleasant stimuli (Pergamin-Hight et al., 2012), some
studies demonstrated that s-allele-carriers, unlike ll-homzygotes,
also selectively attend to pleasant stimuli (Beevers et al., 2009,
2011; Fox et al., 2011). Neuroimaging studies underpin this asso-
ciation, showing heightened neuronal activation in response to
negatively- (Munafo et al., 2008) as well as positively-valenced
stimuli in s-allele-carriers (Canli et al., 2005; Herrmann et al.,
2007; Klucken et al., 2012).
This greater responsiveness to both negative and positive
stimuli in s-allele-carriers also seems to be evident regarding
the impact of life events. Ss-homozygotes are disproportionally
impaired more by negative life events (e.g., Uher and McGuffin,
2008; Karg et al., 2011), but also profit substantially more from
the absence of negative life events—as reviewed by Belsky et al.
(2009)—or a preponderance of positive life events (Taylor et al.,
2006; Pluess et al., 2010; Kuepper et al., 2012).
These findings suggest that the s-allele of the 5-HTTLPR
actually seems to be associated with a general “hypervigilance”
(Homberg and Lesch, 2011) to emotional stimuli of negative
as well as positive valence. Moreover, research on gene × envi-
ronment (G × E) interactions could explain why there is no
direct association between the 5-HTTLPR-genotype and posi-
tive emotionality, thus highlighting the moderating role of the
5-HTTLPR-genotype.
We investigated the association between two indicators of
serotonergic functionality (i.e., acute neuroendocrine response
to S-citalopram and the 5-HTTLPR-genotype) and habit-
ual positive emotionality, expecting a moderating effect of
5-HTTLPR-genotype. This was based on findings regarding G ×
E interactions concerning psychological outcomes as well as
first indications that serotonergic activity is especially influ-
enced by environmental factors in s-allele-carriers (Bennett et al.,
2002; Manuck et al., 2004). Thus, it is conceivable that the
strength of an association between serotonergic functionality
and positive emotionality varies depending on genotype. If the
hypothesized effect is valid, a main effect of acute responsiv-
ity should be weak or absent, explaining previous inconclusive
findings.
MATERIALS AND METHODS
PARTICIPANTS
Participants were recruited at the University of Giessen and via
announcements in a local magazine; offering C 150 for partic-
ipation. Seventy-two males were carefully selected on the basis
of their 5-HTTLPR-genotype as well as a polymorphism in the
TPH-2 gene (rs4570625; G-703T; for details see “Genotyping”)
and if they met the following criteria: Caucasian ethnicity, age
between 18 and 33, right-handedness, non-smoker for at least
1 year, no current or history of psychiatric or physical disor-
ders (i.e., neurological or chronic diseases), no current use of
any medication, no drug or alcohol abuse, coffee-consumption
below 8 cups per day and a body mass index (BMI) between
19 and 25.4. The listed criteria were assessed via self-report.
Additionally, subjects with a Beck Depression Inventory-score
above 17 were excluded (German translation, Hautzinger et al.,
1995), and an adapted version of the Mini-DIPS (Margraf, 1994)
with the screening items in written format was administered.
If necessary, the respective part of the structured interview was
conducted.
Four participants had to be excluded after study-participation
because of missing data (N = 1) or abnormal measurement
results in cortisol samples (N = 3). Therefore, the final data
analyses are based on 68 participants (mean age 24.2 ± 2.6 years).
Before participating in the study, participants were fully
informed about the objective of the study, the administered sub-
stance, and possible side effects of S-citalopram, and written
informed consent was obtained. They were further instructed
how to behave on the day of the testing-sessions as well as on the
evening before; essentially to refrain from alcohol-, medication-
or drug-use, go to bed before 12 p.m. and have lunch before 1
p.m. on the day of the testing-session. The study protocol was
approved by the ethics committee of the German Association of
Psychology (DGPs).
PERSONALITY
Positive Emotionality (PEM) was assessed through the brief
form of the Multidimensional Personality Questionnaire (MPQ-
BF, German translation: Angleitner et al., 1993). The MPQ-BF
(Patrick et al., 2002) additionally measures Negative Emotionality
and Constraint, with 155 items in total in a dichotomous for-
mat (true = 1, false = 0). The PEM-scale is comprised of
four subscales: Wellbeing, Social Potency, Social Closeness, and
Achievement. The total score is obtained by summing up the
respective 36 items, yielding scores between 0 and 36.
PROCEDURE
Participants were given 10mg S-citalopram (orally, Cipralex®,
Lundbeck, Germany) during one testing-session and placebo dur-
ing the other in a double-blind randomized crossover-design. We
chose a dosage of 10mg, because prior studies showed a lack
of side effects as well as an equal proportion of responders and
non-responders in the cortisol response—a desirable prerequisite
Frontiers in Human Neuroscience www.frontiersin.org August 2013 | Volume 7 | Article 486 | 2
Wielpuetz et al. Serotonergic predictors of positive emotionality
to investigate interindividual differences in the responsivity of the
serotonergic system (Kuepper et al., 2006).
The interval between the two sessions was exactly 14 days
(20 days in only one individual) to ensure a sufficient wash-
out period according to the pharmacokinetics of S-citalopram
(Sogaard et al., 2005). The sessions started either at 14:50 h,
15:00 h, 15:10 h, or 15:20 h to enable the testing of four partici-
pants per day.
On arrival, participants were seated in an upright position in
comfortable arm chairs for the whole testing-session. To prevent
boredom, they were allowed to read provided neutral maga-
zines. After a familiarization-period of 15min the baseline saliva
sample was obtained, directly followed by the administration of
either verum or placebo. Further cortisol samples for the chal-
lenge paradigm were collected 50min after drug intake and then
in subsequent 30min-intervals (samples 3–7). Before the sec-
ond sample after 50min, participants completed one of two
questionnaire-sets during each testing-session.
Because of the long testing-interval and to prevent side effects,
participants were offered 100ml of water for the substance-
intakes and, additionally, 50ml after cortisol samples 2, 5, and 7
as well as 100ml water and a soft pretzel after the third sample.
SALIVARY CORTISOL AND RESPONSE MEASURE
Saliva samples were collected with Salivettes® according to
the standard-procedure (Sarstedt, Nuembrecht, Germany). After
every test day saliva samples were centrifuged (10min, 4000 × g)
and frozen immediately at −30◦C for later use. Concentrations
of salivary cortisol levels were determined through use of a com-
mercial enzyme immunoassay (IBL, Hamburg, Germany). All
analyses were performed in duplicates using a fully automated
analyzer (Adaltis, NexGen Four, Freiburg, Germany). All samples
were analyzed within the same lot to avoid inter-assay-variation
due to differences in different charges. The intra-assay-variation
(CV) was lower than 5%.
In order to have a single measure for the serotonergic
responsivity, we calculated the placebo-corrected area under the
response curve (AUC-R) for the cortisol response (Pruessner
et al., 2003). A preliminary analysis of the cortisol responses
showed significant differences between the cortisol responses
under placebo and S-citalopram for samples 4–6 (ps ≤ 0.008)
and a trend for sample 7 (p = 0.066). Therefore, areas under the
curves (AUCs) were calculated for samples 3–7, using sample 3 as
baseline. Finally, the placebo corrected AUC-Rwas determined by
subtracting the AUC for placebo from the AUC for S-citalopram
(Figure 1).
ADVERSE SIDE EFFECTS
To monitor possible side effects, participants’ somatic symptoms
were assessed using a visual analog scale (VAS)—ranging from 1
(no, not at all) to 100 (yes, completely)—with each saliva sam-
ple. The somatic symptom items comprised typical adverse side
effects of S-citalopram, i.e., nausea, drowsiness, nasal conges-
tion, dizziness, diarrhea, headache, mouth dryness and blurred
vision. For statistical analysis regarding side effects, all somatic
symptoms were summed up, separate for each time point (1–7).
There was neither a significant effect of substance compared to
FIGURE 1 | Mean cortisol levels for both placebo and S-citalopram
conditions for samples 1–7. Error bars indicate the SEM. The area
between the curves for S-citalopram and placebo for samples 3–7
(80–200min after substance intake) is represented in the AUC-R. ANOVAs
for repeated measures showed a significant interaction: substance × time
point [F(2.1, 144.1) = 3.71, p = 0.023, Greenhouse–Geisser-adjusted]. This
analysis was based on N = 67 participants, as one participant had a missing
cortisol-sample for the second time point. (∗p < 0.01, ∗∗p < 0.001,
+p = 0.066).
placebo [F(1, 67) = 1.68, p = 0.20] nor a significant interaction
between substance and time point [F(4.2, 278.3) = 0.76, p = 0.56].
Therefore, there were no adverse side effects of S-Citalopram,
which was expected, due to the very low dosage of 10mg (Kuepper
et al., 2006).
GENOTYPING
DNAwas extracted from buccal cells using a standard commercial
extraction kit (High Pure PCR Template Preparation Kit; Roche,
Mannheim, Germany) in a MagNA Pure LC System (Roche).
Genotyping for the 5-HTTLPR was performed in our lab as
described previously by Alexander et al. (2009).
Participants were invited according to their genotype for 5-
HTTLPR as well TPH-2 rs4570625, aiming at 4 equal cells. As
part of another study, it was intended to investigate the joint
influence of these two polymorphisms. Accordingly, participants
were classified into s-allele-carriers or ll-homozygotes for the
5-HTTLPR (frequencies see Table 1) and T-allele-carriers vs.
GG-homozygotes for the rs4570625.
Table 1 | Sample sizes, age, BMI, and AUC-R separated for
5-HTTLPR-genotype-groups (ss, sl, and ll).
ss sl ll
n 10 22 36
age 24.40 ± 2.59 24.41 ± 2.93 24.06 ± 2.46
BMI (kg/m2) 23.33 ± 1.76 22.85 ± 1.87 22.53 ± 1.80
AUC-R 2.75 ± 7.78 3.04 ± 5.38 3.68 ± 8.19
Means ± SDs for age, BMI, and AUC-R are reported.
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DATA ANALYSES
To test for possible confounding factors (age, BMI), analyses
of variance (ANOVA) or correlation analyses were conducted.
Normal distributions of the PEM-scores and the AUC-R were
verified through the Kolmogorov-Smirnov-test.
We tested for relevant predictors of PEM, using regression
analyses, which enabled us to investigate potential mediator or
moderator effects of 5-HTTLPR-genotype (more precisely, lin-
ear effects of an individual’s number of s-alleles) and AUC-R
(Baron and Kenny, 1986). In order to prevent problems of mul-
ticollinearity regarding the interaction term, AUC-R-values were
standardized (AUC-Rz) (Aiken and West, 1991).
First we conducted a regression analysis with only 5-HTTLPR-
genotype entered to predict the AUC-R in order to test for the
mediating effect.
In a second analysis, a hierarchical regression analysis (step-
wise) was performed. Since neither PEM-scores nor 5-HTTLPR-
genotype were associated with age and BMI (see results), these
variables were not included. 5-HTTLPR-genotype (1 = ll, 2 = sl,
3 = ss, indicating an increasing number of 5-HTTLPR s-alleles),
standardized AUC-R values (AUC-Rz) and the interaction term
5-HTTLPR-genotype × AUC-Rz were entered consecutively.
Post-hoc analyses for significant predictors were conducted using
ANOVAs or correlation analyses. Results were considered signifi-
cant with p < 0.05 (two-tailed).
RESULTS
Prior to themain analysis we tested whether 5-HTTLPR-genotype
or AUC-R was associated with age or BMI. 5-HTTLPR-genotype-
groups did not differ with respect to age [F(2, 65) = 0.15, p =
0.86] or BMI [F(2, 65) = 0.80, p = 0.46] (see Table 1). Likewise,
the AUC-R was not significantly associated with age (r = 0.07,
p = 0.55) or BMI (r = 0.11, p = 0.38).
PEM-scores (M = 31.11, SD = 8.23) as well as the AUC-R
(M = 2.98, SD = 7.06) were distributed normally (PEM: Z =
0.81, p = 0.54; AUC-R: Z = 0.61, p = 0.76).
Regression analysis revealed no significant association between
5-HTTLPR-genotype (i.e., number of s-alleles) and AUC-Rz [β =
0.01; R = 0.04, F(1, 66) = 0.13, p = 0.72, R2 = 0.002]. In order
to exclude the possibility that differences between the genotype-
groups were non-linear (and hence would not be detected by
regression analyses), an ANOVA was performed. But likewise,
there were no significant differences regarding AUC-R values
between 5-HTTLPR-genotype-groups [F(2, 65) = 0.07, p = 0.94;
also see Table 1]. Consequently, it could be ruled out that the
AUC-R functions as a mediator of a possible association of
5-HTTLPR-genotype and PEM.
A hierarchical regression analysis was conducted to examine
whether markers of serotonergic system activity (i.e., 5-HTTLPR,
AUC-R) predict PEM. Since age and BMI were not associated with
either predictor and, additionally, were not associated with PEM-
scores themselves (age: r = −0.10, p = 0.43; BMI: r = −0.01,
p = 0.96), both variables were disregarded for further analyses.
The first significant model [R = 0.24, F(1, 66) = 4.2, p = 0.045;
R2 = 0.059] showed only the 5-HTTLPR-genotype to be a sig-
nificant predictor of PEM-scores (β = 0.24, p = 0.045), whereas
the AUC-RZ was non-significant and hence excluded (β = 0.23,
p = 0.053). Inclusion of the interaction term lead to a sec-
ond significant model [R = 0.35, F(2, 65) = 4.5, p = 0.014; R2 =
0.122, R2 = 0.063], rendering the interaction term 5-HTTLPR
× AUC-Rz significant (β = 0.25, p = 0.034) and thereby mini-
mally reducing the weight of the 5-HTTLPR-genotype (β = 0.23,
p = 0.053). The AUC-Rz still remained excluded (β = 0.03,
p = 0.90).
To further evaluate the results, post-hoc analyses were per-
formed. Though the regression analysis revealed a linear associ-
ation between the 5-HTTLPR-genotype and PEM-scores, differ-
ences between 5-HTTLPR-genotype-groups were not significant
[F(2, 65) = 2.1, p = 0.14], while the linear association can clearly
be seen in the data (see Figure 2).
Since the significant interaction term indicates 5-HTTLPR-
genotype specific associations between the AUC-RZ and PEM-
scores, simple correlation analyses were performed separated
for 5-HTTLPR-genotype-groups. We found a significantly pos-
itive correlation between AUC-R and PEM-scores for the ss-
homozygotes (r = 0.70, p = 0.023) but no associations for either
the sl-heterozygotes (r = 0.25, p = 0.27) or the ll-homozygotes
(r = 0.17, p = 0.33) (see Figure 3).
Although the effect of the AUC-R was not significant, we
repeated our analysis with keeping the AUC-R in the regression
model. When entering both the AUC-R and the interaction term
simultaneously, neither reached significance [AUC-R: β = 0.03,
p = 0.91; AUC-R × 5-HTTLPR: β = 0.23, p = 0.39; R = 0.35,
F(3, 64) = 3.0], indicating only the 5-HTTLPR-genotype as a sig-
nificant predictor of positive emotionality (β = 0.24, p = 0.045).
To get a clearer picture of the nature of associations depicted in
our first regression model, however, we additionally analyzed the
correlation between the AUC-R and positive emotionality only
within the group of l-allele-carriers (i.e., sl and ll). Interestingly,
we observed no association between the AUC-R and positive
FIGURE 2 | Mean scores for positive emotionality separated for
5-HTTLPR-genotype. Error bars indicate the SEM. While the ANOVA was
insignificant, when contrasting only ss-homozygotes vs. ll-homozygotes,
we detected a trend for significantly increased scores of positive
emotionality in ss-homozygotes [T(65) = 1.89, p = 0.063].
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FIGURE 3 | Correlations between the AUC-R (raw data) and positive emotionality separated for 5-HTTLPR-genotype: ss, sl, and ll.
emotionality within this group (r = 0.18, p > 0.15). This clearly
indicates that the aforementioned interaction term is based on the
associations between AUC-R and positive emotionality within ss-
homozygotes (r = 0.70, p = 0.023). We are convinced that this
alternative strategy of data analysis turned out to confirm our
previous regression analysis and the relevance of the interaction
term.
DISCUSSION
Based on the assumption that the central serotonergic system
has a non-specific modulatory function on behavior (Spoont,
1992; Depue and Collins, 1999) and not exclusively on avoid-
ance behavior and negative affect, we aimed to further elucidate
its contribution to positive emotionality.
We did not find a direct association between positive emotion-
ality and the acute functionality of the serotonergic system but
somewhat remarkably with the 5-HTTLPR-genotype. That is, an
increasing number of s-alleles was associated with increasing pos-
itive emotionality. Most notable, however, was the hypothesized
moderating role of the 5-HTTLPR-gentoype on the association
between acute serotonergic activity and positive emotionality.
Such an association was found exclusively in ss-homozygotes.
Thereby, it seems that only in ss-homozygotes the acute sero-
tonergic system activity contributes additionally to the degree of
positive emotionality.
Furthermore, our design allowed us to investigate the
influence of 5-HTTLPR-genotype on central serotonergic
responsivity. In vitro studies indicate a functional impact of
5-HTTLPR-genotype, with a higher transcriptional efficiency
of the 5-HTT-gene as well as increased serotonin reuptake
for the l-allele compared to the s-allele (Lesch et al., 1996;
Greenberg et al., 1999). Corresponding PET- and SPECT-studies,
however, yielded contradictory results. Considering only those
studies using [11C]DASB, the radioligand considered to be most
appropriate (Willeit and Praschak-Rieder, 2010), some found
an increased serotonin transporter binding in ll-homozygotes
compared to s-allele-carriers (Praschak-Rieder et al., 2007;
Reimold et al., 2007; Kalbitzer et al., 2009), while Murthy et al.
(2010), using the largest sample, could not show a functional
influence. Also Christian et al. (2009) did not find any association
in non-human primates, likewise pointing to no unequivocal
evidence for a functional influence in vivo.
Furthermore, our results are in line with those neuroendocrine
challenge studies in healthy participants finding no or only weak
evidence for functional consequences (Manuck et al., 2004; Smith
et al., 2004; Wong et al., 2008). Only Whale et al. (2000) demon-
strated a blunted prolactin response for ss-homozygotes. They,
however, used clomipramine, which does not act selectively only
on the serotonergic system (Tatsumi et al., 1997). Thus, evi-
dence suggests that the 5-HTTLPR does not appear to have robust
functional consequences in vivo.
In addition, certain aspects of our study design would have
been advantageous to detect a putative association. With S-
citalopram we used the most specific SSRI (Owens et al., 2001)
currently available in a placebo-controlled design. This ideally
ensures exclusive assessment of net responsivity of the sero-
tonergic system. Furthermore, our sample was considerably
larger than most of the studies cited and consisted of healthy
males only. Thereby, we excluded confounding effects of vary-
ing estrogen levels across the menstrual cycle that exert influ-
ence on the hypothalamus as well as the serotonergic system
(McEwen, 2001). In addition, the sample consisted of compa-
rably young participants, which excluded an influence of age
on the serotonin transporter binding potential as shown by
Kalbitzer et al. (2009).
Nonetheless, we showed positive emotionality to increase with
the number of s-alleles. This finding was remarkable, since nearly
no study has demonstrated such an association when person-
ality was measured (e.g., Lesch et al., 1996; Sen et al., 2004;
Terracciano et al., 2010). This might be explained by two aspects.
Firstly, while most of the respective studies (e.g., Lesch et al.,
1996; Terracciano et al., 2010) used the NEO-PI-R (Costa and
McCrae, 1992), we assessed positive emotionality rather than
extraversion through the MPQ. The MPQ is considered to be an
emotional-temperament inventory reflecting interindividual dif-
ferences in the underlying emotional response systems (Tellegen,
1985; Patrick et al., 2002; Tellegen and Waller, 2008) of the traits
of positive and negative emotionality that are conceptually par-
allel with Depue’s postulated affective personality dimensions
(Depue and Lenzenweger, 2001). This means that high scores
in this scale for positive emotionality would indicate a height-
ened responsiveness to emotional stimuli. Specifically, such an
increased reactivity for positive as well as negative emotional
stimuli has been demonstrated in s-allele-carriers several times
(e.g., Canli et al., 2005; Herrmann et al., 2007; Beevers et al.,
2009). One could, insofar, speculate that the MPQ more closely
depicts emotional responsiveness and reflects its biological under-
pinnings more adequately. Moreover, there is evidence that NEO
extraversion and MPQ positive emotionality do not represent the
same construct (Church, 1994).
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A second explanation might be the highly selected sample.
We carefully made sure to exclude participants with psychi-
atric disorders. When bearing G × E interactions in mind, it
could be hypothesized that by excluding volunteers with higher
depression symptoms we especially excluded s-allele-carriers with
predominantly negative life events in favor of s-allele-carriers
with a preponderance of positive life events and thus possibly
higher positive emotionality. In other words, studies including
participants with higher scores in neuroticism may be at risk
of masking effects for positive emotionality. This hypothesis is
further supported by Minelli et al. (2011), who demonstrated
that associations between the 5-HTTLPR and anxiety-related
traits only exist in samples heterogenous regarding the mental
health status.
In conclusion, there is evidence that there is, indeed, a
detectable albeit weak association between 5-HTTLPR-genotype
and positive emotionality; whereby further research is needed
to disentangle the specific effects of those factors men-
tioned above, which seem to influence the detection of this
association. Hereof, life events appear to be an especially
promising candidate.
The influence of 5-HTTLPR-genotype was not mediated
by the acute responsivity of the serotonergic system. Instead,
the 5-HTTLPR-genotype took on the role of a modera-
tor; i.e., the functionality of the serotonergic system was
positively linked to positive emotionality in ss-homozygotes
only.
An elevated cortisol response can be interpreted as indexing
a reduced overall activity of the serotonergic system. The puta-
tive reason for an elevated cortisol response is an upregulation
or sensitization of postsynaptic receptors, caused by a habitu-
ally diminished serotonin release (Hennig et al., 2005). Within
this line of reasoning, our results support Depue’s theory, which
postulates that a reduced serotonergic functionality lowers the
threshold for response elicitation, which, in turn, should manifest
in temperamental traits (Depue and Collins, 1999). Importantly,
however, we demonstrated this effect in ss-homozygotes only.
At this point, one could only speculate why differences in
the serotonergic responsivity are only linked to personality in
ss-homozygotes. Despite the presumably lacking functional con-
sequences of the 5-HTTLPR-genotype in vivo, evidence neverthe-
less suggests that it is associated with emotional processing and
personality even in healthy participants.
To integrate these divergent findings, it seems plausible
that the 5-HTTLPR-genotype exerts some of its effects pri-
marily during the ontogeny of the central nervous system.
Nordquist and Oreland (2010) as well as Whitaker-Azmitia
(2005) have summarized findings regarding the neurotrophic
effects of serotonin. They argue that an excess of serotonin dur-
ing early neuronal development—which might be caused by
the short variant of the 5-HTTLPR—could lead to morpholog-
ical and functional changes, including circuits involved in emo-
tional processing as well as in serotonergic neurons themselves,
thereby likely leading to behavioral and emotional alterations in
later life.
This reasoning fits to the observed alterations in neuronal
circuits associated with emotional processing (e.g., Hariri et al.,
2002; Canli et al., 2005; Heinz et al., 2005; Pezawas et al., 2005),
which are likely to account for the hypervigilance in s-allele-
carriers (Homberg and Lesch, 2011). Based on these consider-
ations, one might interpret our data as indicating that acute
variations in the functionality of the serotonergic system, indeed,
only modulate positive emotionality in those subjects who are
genetically predisposed. Underpinning this, there is evidence that
5-HTTLPR-genotype moderates the effects of, e.g., acute tryp-
tophan depletion on mood and behavior (Marsh et al., 2006;
Neumeister et al., 2006; Markus and Firk, 2009; Markus and De
Raedt, 2011), pointing to a higher vulnerability to alterations in
the serotonergic neurotransmission in ss-homozygotes.
The main reason for this study regarding the associa-
tion of the serotonergic system and positive emotionality was
Depue’s postulate (Depue and Collins, 1999) of the seroton-
ergic system as a general threshold modulator. One could
further speculate on an essential contribution of the oxy-
tocinergic system to positive emotionality, not least because
Depue (Depue and Lenzenweger, 2001; Depue and Morrone-
Strupinsky, 2005; Depue and Fu, 2011) also linked com-
ponents of positive emotionality—namely affiliation—to the
oxytocinergic system.
Indeed, there a several additional arguments that suggest that
effects of oxytocin could have, at least partially, contributed to
our results. Firstly, there is a co-localization of oxytocin-labeled
cells and serotonin-transporter-labeled fibers in the paraventric-
ular (PVN) and supraoptic nuclei (SON) of the hypothalamus
(Emiliano et al., 2007). Secondly, oxytocin-release is influenced
by acute serotonergic neurotransmission: exogenous serotonin as
well as several serotonin-receptor agonists (primarily via 5-HT1A,
5-HT2C, and 5-HT4 receptors) lead to an increase in plasma
oxytocin levels (Jorgensen et al., 2003). Importantly, the acute
administration of citalopram also increases the concentration of
oxytocin in the plasma (Uvnas-Moberg et al., 1999) as well as
levels of oxytocin-mRNA within the magnocellular regions of
the PVN (Hesketh et al., 2005). Regarding a possible influence
on the cortisol-release to S-citalopram in our study, there is evi-
dence that central oxytocin-release leads to attenuated endocrine
responses to acute stress; i.e., glucocorticoids and ACTH, as was
shown in studies administering oxytocin directly (Windle et al.,
1997; Heinrichs et al., 2003; Parker et al., 2005; Ditzen et al.,
2009).
The interaction of both systems, therefore, could have
contributed to the association of positive emotionality with
the cortisol-response to S-citalopram to some degrees (also,
if in ss-homozygotes only). The exact consequences of the
influence of oxytocin are, however, hard to specify (because
of a contribution of levels of both neurotransmitters as
well as various involved receptors). One could only specu-
late, whether oxytocinergic influences also contribute to our
association of 5-HTTLPR-genotype with positive emotional-
ity, which cannot be ruled out; not least due to additional
neurodevelopmental effects of serotonin on the oxytocin-
ergic system (Whitaker-Azmitia, 2005). Future research is
needed to allow further conclusions in this respect (e.g.,
measures of plasma oxytocin-levels in a neuroendocrine
challenge-paradigm).
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Another point to keep in mind when interpreting our data,
is that in light of the postulated general hypervigilance associ-
ated with the 5-HTTLPR s-allele (Homberg and Lesch, 2011),
as well as Depue’s understanding of the serotonergic system as
a threshold modulator for both, approach and avoidance (e.g.,
Depue and Collins, 1999), one would expect similar results
for the personality traits of negative emotionality. Therefore,
we reanalyzed our data for negative emotionality (also assessed
using the MPQ). Importantly, positive and negative emotional-
ity are assumed to be two independent dimensions (e.g., Tellegen
and Waller, 2008), which is supported by our data (r = −0.14,
p = 0.24). The regression analysis did not show the 5-HTTLPR-
genotype, the AUC-R or the interaction term to be associated
with negative emotionality (for all βs, ps > 0.50). Though some-
what surprising, this result clarifies that the association of the
serotonergic predictors of positive emotionality do not simply
reflect an association with negative emotionality, but rather a dis-
tinct association with positive emotionality. Nevertheless, based
on the above mentioned assumptions, one would rather have
expected associations to both, positive and negative emotion-
ality. Returning to our foregoing explanation for the results
regarding positive emotionality and the 5-HTTLPR-genotype
(i.e., the highly selected sample), this also seems to explain
this possible lack of association. Following this explanation, we
potentially excluded especially 5-HTTLPR s-allele-carriers with a
high incidence of negative life events that display higher scores
in neuroticism (e.g., Kuepper et al., 2006; Pluess et al., 2010)
and more depression symptoms (e.g., Caspi et al., 2003; Taylor
et al., 2006). Likewise, this is in accordance with the results
by Minelli et al. (2011), showing that the 5-HTTLPR-genotype
is only associated with anxiety-related traits in heterogenous
samples.
Certain limitations of our study must be kept in mind:
as far as molecular genetic studies are concerned, our sam-
ple was relatively small, and we only tested males. Replications
are therefore clearly needed, especially in females. Furthermore,
our reasoning concerning the underlying mechanisms is spec-
ulative, and future research should shed light on factors that
(a) foster the association between the 5-HTTLPR and posi-
tive emotionality and (b) contribute to the acute serotonergic
functionality that in turn could also shape personality traits.
Reasonable candidates would be life events or other genetic
variations.
Initial evidence for an influence of living conditions stems
from a study byManuck et al. (2004). They demonstrated that the
association between the prolactin response to fenfluramine and
the socio-economic status is moderated by 5-HTTLPR-genotype.
This finding is further supported by Bennett et al. (2002), who
found that the influence of early rearing conditions on the con-
centration of the serotonin metabolite 5-hydroxyindolacetic acid
(5-HIAA) in the cerebrospinal fluid is moderated by the rh5-
HTTLPR-genotype in rhesus macaques.
Beyond this, further research should investigate the stability
of the responsivity of the serotonergic system, which seems to be
influenced by life events.
To our knowledge, this was the first study to specifically
investigate the combined effects of both stable genetic variations
and the acute responsivity of the serotonergic system on varia-
tions in positive emotionality. According to Depue, a diminished
serotonergic functionality should ultimately amplify both posi-
tive and negative emotionality (Depue and Collins, 1999). Our
results partly support this assumption in that ss-homozygotes
manifest the highest positive emotionality. Furthermore, at
least in ss-homozygotes, a reduced serotonergic functional-
ity is, in turn, associated with higher positive emotionality.
The results highlight the need to focus not only on neg-
ative affectivity and related processes but also on positive
affectivity to fully understand the role of the serotonergic
system.
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